SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Organogenesis ORG -- Ignore unavailable to you. Want to Upgrade?

To: CMason who wrote (1120)8/26/1998 12:30:00 PM
From: Rick Strange  Respond to of 1223
 
I think that the Post got it wrong. If there were a new study ORG would have released the information by now to attempt to halt the downward drift of the stock. Also, Novartis wouldn't be spending $ millions to rerun the trials with a group of patients with ulcers of less than one year duration.

I agree with your comments about the negative impact on marketing efforts and third party approval. The lack of sales to-date confirm this.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News